|
Durable
response of breast cancer leptomeningeal metastasis to capecitabine monotherapy
Lisa
R. Rogers, Sandra E. Remer, Sheela Tejwani
Hermelin Brain Tumor Center, Departments of Neurosurgery
(L.R.R., S.E.R.) and Neurology (L.R.R.), Henry Ford Hospital, Detroit, MI 48202,
and Josephine Ford Cancer Center (S.T.), Detroit, MI 48202; USA.
We
report a durable (12-month) response to capecitabine monotherapy, shown
clinically, by MRI, and by cerebrospinal fluid analysis, in a patient with
leptomeningeal metastasis from breast cancer.
© 2003 Duke University Press
Source: http://dandini.ingentaselect.com/vl=2874912/cl=18/nw=1/rpsv/cgi-bin/linker?ini=dup_no&reqidx=/cw/dup/15228517/v6n1/s10/p63
|
